Targeted delivery of vitamin E TPGS based nanomedicine for treatment of triple negative breast cancer

QR Code

Targeted delivery of vitamin E TPGS based nanomedicine for treatment of triple negative breast cancer

Triple negative breast cancers (TNBC) can be classified as one of the most aggressive with a high rate of local recurrences and systematic metastases. TNBCs are insensitive to existing hormonal therapy or targeted therapies such as the use of monoclonal antibodies, due to the lack of estrogen recept...

Full description

Bibliographic Details
Main Author:	Rajaletchumy, Veloo Kutty
Format:	Thesis
Language:	English
Published:	2015
Subjects:	R Medicine (General)
Online Access:	http://umpir.ump.edu.my/id/eprint/16959/ http://umpir.ump.edu.my/id/eprint/16959/19/Targeted%20delivery%20of%20vitamin%20E%20TPGS%20based%20nanomedicine%20for%20treatment%20of%20triple%20negative%20breast%20cancer.pdf

Similar Items

Physical characterization of propolis encapsulated vitamin E TPGS as nanomedicine (Corrected Proof)
by: Tong Kong, Yee, et al.
Published: (2021)

Recent advances in nanotheranostics for triple negative breast cancer treatment
by: Thakur, Vikram, et al.
Published: (2019)

Nanomedicine using Quercus infectoria Extract for the treatment of Breast Cancer
by: Wan Nur, Suzilla, et al.
Published: (2020)

Evaluation of the co-delivery of diagnostic and therapeutic agents in polymeric micelles for triple negative breats cancer treatment
by: Nurul Issttifa Iyah, Aminuddin, et al.
Published: (2019)

Passerini multicomponent reaction: a versatile synthesis of nanomedicines for triple negative breast cancer treatment
by: Travanut, Alessandra
Published: (2021)

Preliminary studies on extraction of propolis using vitamin E d-ɑ-tocopheryl polyethylene glycol succinate (vitamin E TPGS) and compare their antimicrobial activities
by: Yee, Tong Kong, et al.
Published: (2020)

Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)

The identification of targeting peptides and tumour associated antigens for the treatment and early detection of triple negative breast cancer
by: Wilde, Megan
Published: (2023)

Wnt signaling in triple-negative breast cancer
by: Pohl, S., et al.
Published: (2017)

Investigations of bioresponsive polymers in triple negative breast cancers
by: Monteiro, Patricia
Published: (2019)

Triple negative breast cancer in Asia: An insider's view
by: Wang, C., et al.
Published: (2018)

Development and characterization of a theranostic micelles system using TPGS with docetaxel and coumarin-6: a dual polymeric nanocarrier system
by: Ching, L.H., et al.
Published: (2018)

Enhancing breast cancer treatment: investigating the influence of polymer ratios on Luteolin-loaded TPGS/poloxamer micelles
by: Mod Razif, Muhammad Redza Fahmi, et al.
Published: (2024)

Apoptosis and cell cycle mechanisms of ampelopsin E on triple negative breast cancer cells
by: Abd Rahman, Napsiah
Published: (2017)

The role of HOXA5 in triple-negative breast cancer (TNBC)
by: Mahmoud, Rinad
Published: (2021)

Integrative molecular and pathologic profiling of triple negative breast cancer
by: Alsaleem, Mansour
Published: (2021)

Selective targeting of cancer signaling pathways with nanomedicines: challenges and progress
by: Abul Barkat, Harshita, et al.
Published: (2020)

In silico investigations and potential approaches of Tectona grandis via targeting MMP-9 for triple negative breast cancer
by: Permana, Sofy, et al.
Published: (2024)

The clonal and mutational evolution spectrum of primary triple-negative breast cancers
by: Shah, S., et al.
Published: (2012)

Ampelopsin E reduces the invasiveness of the triple negative breast cancer cell line, MDA-MB-231
by: Tieng, Francis Yew Fu, et al.
Published: (2019)

The role of sodium driven bicarbonate transporters in triple negative breast cancer metastasis
by: Carroll, Christopher
Published: (2020)

A clinicopathologic study on triple-negative breast cancer patients: HUSM experience
by: Saidin, Usman Sani
Published: (2011)

Genetic determinants of TAC chemotherapy response in triple negative breast cancer patients
by: Aziz, Ahmad Aizat Abdul
Published: (2018)

Engineering apoferritin for targeted delivery of peptides or proteins for the treatment of breast cancer
by: Ferreira, Lenny
Published: (2023)

The association of ICAM-1 detected by immunohistochemical staining with triple negative and non-triple negative breast carcinoma
by: Chong, Choi Yen, et al.
Published: (2019)

Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines
by: Khor, Poh Yen, et al.
Published: (2021)

Effects of ampelopsin E towards the invasiveness of triple negative breast cancer cell line, MDA-MB-231
by: Tieng, Francis Yew Fu
Published: (2019)

The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells
by: Etti, Imaobong Christopher, et al.
Published: (2017)

Calpain system protein expression in basal-like and triple-negative invasive breast cancer
by: Storr, Sarah J., et al.
Published: (2012)

Profiling of gene and exosomal microRNA as therapy targets and biomarkers of cisplatin resistance in triple negative breast cancer stem cell-like subpopulation
by: Koh, May Zie
Published: (2021)

Mediation of triple-negative breast cancer cell fate via cellular redox and Wnt signalling
by: Pohl, Sebastian Öther-Gee
Published: (2018)

Systematic review on the efficacy and safety of ixabepilone-based chemotherapy regimen in triple-negative breast cancer
by: Azizah, Maghfira Rahma, et al.
Published: (2024)

Development of drug delivery systems based on layered hydroxides for nanomedicine
by: Barahuie, Farahnaz, et al.
Published: (2014)

PARP inhibitor combinations with Olaparib for synergistic efficacy in Olaparib-resistant triple-negative breast cancer cells
by: Yusoh, Nur Aininie
Published: (2023)

Polyadenylation as a target for the treatment of breast cancer
by: Thiyab, Asraa
Published: (2025)

High CD4+/CD8+ Intratumour Ratio is associated with favourable outcome in triple-negative Breast Cancer
by: Thian, Q.Z., et al.
Published: (2022)

Therapeutic potential of albumin nanoparticles encapsulated visnagin in MDA-MB-468 triple-negative breast cancer cells
by: Alsrhani, Abdullah, et al.
Published: (2023)

Evaluation of palm oil mill effluent (POME) by membrane anaerobic system (MAS)
by: Rajaletchumy, Veloo Kutty
Published: (2010)

Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer
by: Dent, R., et al.
Published: (2013)

Induction of apoptosis and G2/M arrest by ampelopsin E from Dryobalanops towards triple negative breast cancer cells, MDA-MB-231
by: Abd Rahman, Napsiah, et al.
Published: (2016)